{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:21:29Z","timestamp":1792120889671,"version":"4.4.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,273,202"],"award-info":[{"award-number":["82,273,202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,372,800"],"award-info":[{"award-number":["82,372,800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042024kf0021"],"award-info":[{"award-number":["2042024kf0021"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2504200"],"award-info":[{"award-number":["2022YFC2504200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbcan.2024.189209","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T21:08:23Z","timestamp":1731618503000},"page":"189209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Erythroid progenitor cell modulates cancer immunity: Insights and implications"],"prefix":"10.1016","volume":"1879","author":[{"given":"Wen-Tao","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Fa","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbcan.2024.189209_bb0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with Ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189209_bb0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer \u2014 mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189209_bb0025","first-page":"147","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy, nature reviews","volume":"21","author":"Lasser","year":"2024","journal-title":"Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189209_bb0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.trecan.2022.04.001","article-title":"Utilizing chemokines in cancer immunotherapy","volume":"8","author":"M\u00e4rkl","year":"2022","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","article-title":"Therapeutic targeting of tumour myeloid cells","volume":"23","author":"Barry","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189209_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109139","article-title":"Tumor-associated macrophages promote migration and invasion via modulating IL-6\/STAT3 signaling in renal cell carcinoma","volume":"111","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189209_bb0045","article-title":"Targeting tumor-associated macrophages for cancer immunotherapy","volume":"1874","author":"Shu","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bbcan.2024.189209_bb0050","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41590-024-01859-0","article-title":"Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade","volume":"25","author":"Fortin","year":"2024","journal-title":"Nat. Immunol."},{"issue":"18","key":"10.1016\/j.bbcan.2024.189209_bb0055","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models","volume":"74","author":"Zhu","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189209_bb0060","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","article-title":"Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy","volume":"25","author":"Ries","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2024.189209_bb0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/gutjnl-2017-313738","article-title":"Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma","volume":"67","author":"Nywening","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2024.189209_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1034842","article-title":"TAM-targeted reeducation for enhanced cancer immunotherapy: mechanism and recent progress","volume":"12","author":"Shen","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189209_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cell.2018.02.061","article-title":"Tumor-induced generation of splenic erythroblast-like Ter-cells promotes tumor progression","volume":"173","author":"Han","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2024.189209_bb0080","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2022.04.018","article-title":"Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1\/PD-L1 treatment efficacy","volume":"40","author":"Long","year":"2022","journal-title":"Cancer Cell"},{"issue":"7299","key":"10.1016\/j.bbcan.2024.189209_bb0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nature09135","article-title":"Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection","volume":"465","author":"Baldridge","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbcan.2024.189209_bb0090","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41591-018-0205-5","article-title":"Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189209_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.it.2019.01.003","article-title":"Neglected cells: immunomodulatory roles of CD71+ erythroid cells","volume":"40","author":"Elahi","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2024.189209_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107927","article-title":"The role of CD71+ erythroid cells in the regulation of the immune response","volume":"228","author":"Grzywa","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.bbcan.2024.189209_bb0105","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2002-03-0864","article-title":"CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn","volume":"100","author":"Harashima","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-2478(79)90032-4","article-title":"A new kind of immunosuppression associated with erythropoiesis","volume":"1","author":"Conway de Macario","year":"1979","journal-title":"Immunol. Lett."},{"issue":"7478","key":"10.1016\/j.bbcan.2024.189209_bb0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nature12675","article-title":"Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection","volume":"504","author":"Elahi","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189209_bb0120","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1172\/JCI97973","article-title":"Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis","volume":"128","author":"Wu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2024.189209_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2020.12.003","article-title":"Intratumoral CD45+CD71+ erythroid cells induce immune tolerance and predict tumor recurrence in hepatocellular carcinoma","volume":"499","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"582","key":"10.1016\/j.bbcan.2024.189209_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0130","article-title":"Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity","volume":"13","author":"Hou","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189209_bb0135","article-title":"Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189209_bb0140","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/s41590-023-01662-3","article-title":"Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR\u2013RUNX1","volume":"24","author":"Zhou","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","article-title":"Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6487","key":"10.1016\/j.bbcan.2024.189209_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189209_bb0155","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","article-title":"What is cancer metabolism?","volume":"186","author":"Finley","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189209_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"7946","key":"10.1016\/j.bbcan.2024.189209_bb0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-022-05605-0","article-title":"Dendritic cells direct circadian anti-tumour immune responses","volume":"614","author":"Wang","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189209_bb0185","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"687","key":"10.1016\/j.bbcan.2024.189209_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6221","article-title":"Neutralization of NET-associated human ARG1 enhances cancer immunotherapy","volume":"15","author":"Cane","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"23","key":"10.1016\/j.bbcan.2024.189209_bb0195","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbcan.2024.189209_bb0200","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41568-018-0054-z","article-title":"Rewiring urea cycle metabolism in cancer to support anabolism","volume":"18","author":"Keshet","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2024.189209_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005326","article-title":"Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells","volume":"10","author":"Weis-Banke","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2024.189209_bb0210","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0215","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13046-023-02888-7","article-title":"Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment","volume":"42","author":"Lv","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0220","first-page":"992","article-title":"Targeting myeloid-derived suppressor cells for cancer therapy","volume":"18","author":"Tang","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189209_bb0225","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01831-w","article-title":"Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis","volume":"22","author":"Ren","year":"2023","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189209_bb0235","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189209_bb0240","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-alpha","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189209_bb0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41590-020-00829-6","article-title":"NF-kappaB-inducing kinase maintains T cell metabolic fitness in antitumor immunity","volume":"22","author":"Gu","year":"2021","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189209_bb0250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0255","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1038\/s41467-020-18745-6","article-title":"Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death","volume":"11","author":"Deng","year":"2020","journal-title":"Nat. Commun."},{"issue":"42","key":"10.1016\/j.bbcan.2024.189209_bb0260","doi-asserted-by":"crossref","first-page":"26008","DOI":"10.1073\/pnas.2009495117","article-title":"Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 ca(2+) signals that are inhibited by oncogenic KRas","volume":"117","author":"Pratt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2024.189209_bb0265","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3389\/fimmu.2019.02298","article-title":"The diverse function of PD-1\/PD-L pathway beyond cancer","volume":"10","author":"Qin","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2024.189209_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104346","article-title":"G-CSF promotes alloregulatory function of MDSCs through a c-kit dependent mechanism","volume":"364","author":"Lee","year":"2021","journal-title":"Cell. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189209_bb0275","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.4049\/jimmunol.1800113","article-title":"CD71+ erythroid suppressor cells promote fetomaternal tolerance through Arginase-2 and PDL-1","volume":"200","author":"Delyea","year":"2018","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.bbcan.2024.189209_bb0280","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1158\/0008-5472.CAN-19-0053","article-title":"Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signaling","volume":"79","author":"Fleming","year":"2019","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189209_bb0285","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1541-7786.MCR-20-0746","article-title":"Multiorgan signaling mobilizes tumor-associated erythroid cells expressing immune checkpoint molecules","volume":"19","author":"Sano","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0290","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transd. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0295","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri704","article-title":"Transforming growth factor-\u03b2 in T-cell biology","volume":"2","author":"Gorelik","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189209_bb0300","article-title":"CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-\u03b2","volume":"16","author":"Marrack","year":"2018","journal-title":"PLoS Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189209_bb0305","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189209_bb0310","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.immuni.2023.11.003","article-title":"Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10","volume":"56","author":"Brockmann","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2024.189209_bb0315","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.molimm.2019.06.021","article-title":"Splenomegaly induced by anemia impairs T cell movement in the spleen partially via EPO","volume":"112","author":"Li","year":"2019","journal-title":"Mol. Immunol."},{"issue":"616","key":"10.1016\/j.bbcan.2024.189209_bb0320","doi-asserted-by":"crossref","first-page":"eabj1008","DOI":"10.1126\/scitranslmed.abj1008","article-title":"DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia","volume":"13","author":"Lam","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040870","article-title":"Tumor immune evasion induced by dysregulation of erythroid progenitor cells development","volume":"13","author":"Grzywa","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.bbcan.2024.189209_bb0330","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2010-03-271791","article-title":"Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric castleman disease","volume":"116","author":"Song","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0335","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2863","article-title":"Tocilizumab","volume":"8","author":"Scheinecker","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.bbcan.2024.189209_bb0340","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1158\/1078-0432.CCR-15-0134","article-title":"Analysis of inflammatory and anemia-related biomarkers in a randomized, double-blind, placebo-controlled study of Siltuximab (anti-IL6 monoclonal antibody) in patients with multicentric castleman disease","volume":"21","author":"Casper","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189209_bb0345","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-014-0249-x","article-title":"Siltuximab: first global approval","volume":"74","author":"Markham","year":"2014","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bbcan.2024.189209_bb0350","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/ar3366","article-title":"Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still\u2019s disease: a case-series study","volume":"13","author":"Laskari","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189209_bb0355","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189209_bb0360","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar4323","article-title":"Comparative evaluation of the effects of treatment with tocilizumab and TNF-alpha inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"10086","key":"10.1016\/j.bbcan.2024.189209_bb0365","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/S0140-6736(17)30068-5","article-title":"Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial","volume":"389","author":"J\u00f8rgensen","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2024.189209_bb0370","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2147\/CMAR.S161746","article-title":"Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review","volume":"10","author":"Bao","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/0008-5472.CAN-20-2339","article-title":"Splenic hematopoietic and stromal cells in cancer progression","volume":"81","author":"Steenbrugge","year":"2021","journal-title":"Cancer Res."},{"issue":"7579","key":"10.1016\/j.bbcan.2024.189209_bb0380","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature15530","article-title":"A perisinusoidal niche for extramedullary haematopoiesis in the spleen","volume":"527","author":"Inra","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189209_bb0385","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.celrep.2014.09.003","article-title":"VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone marrow cell mobilization","volume":"9","author":"Lim","year":"2014","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0390","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1084\/jem.20180752","article-title":"VEGF expands erythropoiesis via hypoxia-independent induction of erythropoietin in noncanonical perivascular stromal cells","volume":"216","author":"Greenwald","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2024.189209_bb0395","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molimm.2019.02.014","article-title":"RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment","volume":"109","author":"Mu","year":"2019","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0400","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10571-013-9995-7","article-title":"Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia","volume":"34","author":"Pevida","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189209_bb0405","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.bbcan.2024.189209_bb0410","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-16-2919","article-title":"Single dose of the CXCR4 antagonist BL-8040 induces rapid mobilization for the collection of human CD34+ cells in healthy volunteers","volume":"23","author":"Abraham","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189209_bb0415","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.2019004017","article-title":"How I treat cancer-associated anemia","volume":"136","author":"Gilreath","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189209_bb0420","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI133678","article-title":"Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes","volume":"130","author":"Verma","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189209_bb0425","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ajh.23786","article-title":"FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis","volume":"89","author":"Zhang","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0430","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0435","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/tbj.13583","article-title":"Intratumoral extramedullary hematopoiesis in solitary fibrous tumor of the breast","volume":"26","author":"Cho","year":"2019","journal-title":"Breast J."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189209_bb0440","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/0300985811432344","article-title":"Extramedullary hematopoiesis: a new look at the underlying stem cell niche, theories of development, and occurrence in animals","volume":"49","author":"Johns","year":"2012","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbcan.2024.189209_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120580","article-title":"PLGA-nanoparticles for intracellular delivery of the CRISPR-complex to elevate fetal globin expression in erythroid cells","volume":"268","author":"Cruz","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0450","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41420-024-01891-x","article-title":"Targeting cell death pathways in intestinal ischemia-reperfusion injury: a comprehensive review","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0455","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2024.189209_bb0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0465","article-title":"Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells","volume":"8","author":"Qin","year":"2023","journal-title":"Signal Transd. Target. Ther."},{"issue":"7893","key":"10.1016\/j.bbcan.2024.189209_bb0470","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-021-04220-9","article-title":"Synthon-based ligand discovery in virtual libraries of over 11 billion compounds","volume":"601","author":"Sadybekov","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0475","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/08820139.2021.1891094","article-title":"Application of emerging plant-derived nanoparticles as a novel approach for Nano-drug delivery systems","volume":"51","author":"Sarvarian","year":"2021","journal-title":"Immunol. Investig."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0480","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/acs.chemrev.1c00553","article-title":"Versatile types of inorganic\/organic NIR-IIa\/IIb fluorophores: from strategic design toward molecular imaging and Theranostics","volume":"122","author":"Liu","year":"2021","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189209_bb0485","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1021\/acs.jmedchem.1c01615","article-title":"Self-assembled NIR-II fluorophores with Ultralong blood circulation for Cancer imaging and image-guided surgery","volume":"65","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189209_bb0490","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.apsb.2023.06.015","article-title":"Antibody\u2013drug conjugates: recent advances in payloads","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189209_bb0495","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.apsb.2023.03.001","article-title":"mRNA delivery in cancer immunotherapy","volume":"13","author":"Zhong","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbcan.2024.189209_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2024.04.007","article-title":"Characteristic roadmap of linker governs the rational design of PROTACs","author":"Dong","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189209_bb0505","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1021\/acsnano.2c08898","article-title":"Development of spleen targeting H2S donor loaded liposome for the effective systemic immunomodulation and treatment of inflammatory bowel disease","volume":"17","author":"Oh","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2024.189209_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101943","article-title":"Spleen-targeted nanosystems for immunomodulation","volume":"52","author":"Wang","year":"2023","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189209_bb0515","article-title":"Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives","volume":"9","author":"Guo","year":"2022","journal-title":"Mil. Med. Res."},{"issue":"27","key":"10.1016\/j.bbcan.2024.189209_bb0520","article-title":"Synergistic lysosomal impairment and ER stress activation for boosted autophagy dysfunction based on Te double-headed Nano-bullets","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"issue":"18","key":"10.1016\/j.bbcan.2024.189209_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202311914","article-title":"Recent advances in nanomodulators for augmenting cancer immunotherapy in cold tumors: insights from drug delivery to drug-free strategies","volume":"34","author":"Zhang","year":"2024","journal-title":"Adv. Funct. Mater."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:01:38Z","timestamp":1777554098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":105,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0304419X24001409"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189209","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythroid progenitor cell modulates cancer immunity: Insights and implications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189209"}}